New B&L manager in Ireland

Article

Colum Honan is to be Bausch & Lomb's general manager with responsibility for its Waterford plant which manufactures contact lenses and other eye health products.

Colum Honan is to be Bausch & Lomb's general manager with responsibility for its Waterford plant which manufactures contact lenses and other eye health products.

He was previously deputy general manager and held a number of positions in which he managed successful projects where new products were taken from design to manufacturing to market launch.

Honan was involved with the successful transfer of the key new PureVision lens from the research and development stage to manufacturing.

In 1999, he was given responsibility as site leader for the industrialization of a new drug application which is now marketed as Retisert, a fluocinolone acetonide intravitreal implant, which represents a dramatic advance in the management of chronic non-infectious uveitis affecting the posterior segment of the eye.

He replaces Frank O'Regan, who last year was named vice president, Operations, Global Vision Care. Honan continues to report to O'Regan.

Welcoming the appointment, Frank O'Regan said: "Colum has a solid record of taking new products and processes from early product development phases right through to successful market launch with maximum efficiency. He takes over responsibility for the Waterford manufacturing site at a very challenging time when his management strengths will be a major asset in steering the business to a successful future."

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Andreas Pollreisz, MD, discusses widefield OCT-A and fluorescence angiography at the 2025 European Society of Retina Specialists EURETINA meeting
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
© 2025 MJH Life Sciences

All rights reserved.